In-House In-Sights: Peter Sheridan

Peter Sheridan has worked in the graphic design field for nearly 30 years practicing in a wide range of disciplines within a variety of industries including publishing, printing, service bureaus, and several small agencies and design studios.

Tapping into his eclectic background to start the in-house design studio in Bristol-Myers Squibb’s Consumer Medicines division in 1992, Peter managed the graphics needs for all of the company’s national consumer brands, including Excedrin, Comtrex, No-Doz, Keri Lotion, and Theragran vitamins. The studio produced everything from packaging and POP displays to promotional and DTC design projects.

During his 15 year tenure at BMS, Peter expanded the department from two designers to a staff of more than 175 employees, managing design projects for every division within the company. He accomplished this by developing a unique “intrapreneurial” approach to the internal graphics business, providing design services, print production management, distribution of all promotional materials and interactive and web design. The department garnered a number of awards including POPAIs, Tellies, Auroras, and Graphic Design USA and HOW Print Awards.

Since leaving BMS, Peter has started a design consultancy firm leveraging his experience and background in design, design management and production working with a diverse clientele ranging from financial services and software development companies to pharmaceutical and medical device corporations. His current projects include corporate branding, product launches, product redesigns, web SEO/SEM strategies, and package design.

Peter takes a real-world brass tacks approach to the business of  in-house design that is deceptively simple and very sophisticated.

{Peter_Interview_Pt1}

.

HOW encourages lively, informative and respectful dialogue. Please do not engage in malicious attacks on individuals or organizations. For more details on proper response etiquette please read our Response Guidelines.

One thought on “In-House In-Sights: Peter Sheridan

COMMENT